Zecevic, A., Sampath, D., Ewald, B., Chen, R., Wierda, W., & Plunkett, W. (2011). Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease. Clin Cancer Res.

Zecevic, Alma, Deepa Sampath, Brett Ewald, Rong Chen, William Wierda, and William Plunkett. "Killing of Chronic Lymphocytic Leukemia By the Combination of Fludarabine and Oxaliplatin Is Dependent On the Activity of XPF Endonuclease." Clin Cancer Res 2011.

Zecevic, Alma, et al. "Killing of Chronic Lymphocytic Leukemia By the Combination of Fludarabine and Oxaliplatin Is Dependent On the Activity of XPF Endonuclease." Clin Cancer Res 2011.